00795nas a2200313   4500000000100000008004100001100001600042700001100058700001600069700001200085700001700097700001800114700001300132700001800145700001400163700001400177700001400191700001700205700001300222700001800235700001500253700001400268700001800282700001900300700001400319700002300333245011100356022001400467       2020                            d1 aD. Robinson1 aM. Ali1 aN. Pallares1 aC. Tebe1 aL. Elhussein1 aB. Abrahamsen1 aN. Arden1 aY. Ben-Shlomo1 aF. Caskey1 aC. Cooper1 aD. Dedman1 aA. Delmestri1 aA. Judge1 aM. Perez-Saez1 aJ. Pascual1 aX. Nogues1 aA. Diez-Perez1 aV . Y. Strauss1 aM. Javaid1 aD. Prieto-Alhambra00aSafety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a bi-national cohort analysis  a0884-0431